{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:49:38Z","timestamp":1785408578676,"version":"3.56.0"},"reference-count":76,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI153071, AI180089"],"award-info":[{"award-number":["AI153071, AI180089"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","award":["Investigator in the Pathogenesis of Infectious Disease"],"award-info":[{"award-number":["Investigator in the Pathogenesis of Infectious Disease"]}],"id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2025,8,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      The obligate human pathogen\n                      <jats:italic toggle=\"yes\">Streptococcus pyogenes<\/jats:italic>\n                      (also known as GAS; Group A\n                      <jats:italic toggle=\"yes\">Streptococcus<\/jats:italic>\n                      ) carries high morbidity and mortality, primarily in impoverished or resource-poor regions. The failure rate of monotherapy with conventional antibiotics is high, and invasive infections by this bacterium frequently require extensive supportive care and surgical intervention. Thus, it is important to find new compounds with adjunctive therapeutic benefits. The conserved secreted protease streptopain (Streptococcal pyogenic exotoxin B; SpeB) directly contributes to disease pathogenesis by inducing pathological inflammation, degrading tissue, and promoting the evasion of antimicrobial host defense proteins. This study screened 400 diverse off-patent drugs and drug-like compounds for inhibitors of streptopain proteolysis. Lead compounds were tested for activity at lower concentrations and anti-virulence activities during\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      infection. Significant inhibition of streptopain was seen for pentamidine, an anti-protozoal drug approved for the treatment of Pneumocystis pneumonia, leishmaniasis, and trypanosomiasis. Streptopain inhibition rendered GAS susceptible to killing by human innate immune cells. These studies identify unexploited molecules as new starting points for drug discovery and a potential for repurposing existing drugs for the treatment of infections by GAS.\n                    <\/jats:p>\n                    <jats:sec>\n                      <jats:title>IMPORTANCE<\/jats:title>\n                      <jats:p>\n                        <jats:italic toggle=\"yes\">Streptococcus pyogenes<\/jats:italic>\n                        is a common cause of severe invasive infections. Repeated infections can trigger autoimmune diseases such as acute rheumatic fever and rheumatic heart disease. This study examines how targeting a specific, highly conserved virulence factor of the secreted cysteine protease streptopain can sensitize a serious pathogen to killing by the immune system. Manipulating the host-pathogen interaction, rather than attempting to directly kill a microbe, is a promising therapeutic strategy. Notably, its benefits include limiting off-target effects on the microbiota. Streptopain inhibitors, including the antifungal and antiparasitic drug pentamidine as identified in this work, may therefore be useful in the treatment of\n                        <jats:italic toggle=\"yes\">S. pyogenes<\/jats:italic>\n                        infection.\n                      <\/jats:p>\n                    <\/jats:sec>\n                  <\/jats:sec>","DOI":"10.1128\/spectrum.00758-25","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T09:04:42Z","timestamp":1750669482000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":3,"title":["Pentamidine inhibition of streptopain attenuates\n                    <i>Streptococcus pyogenes<\/i>\n                    virulence"],"prefix":"10.1128","volume":"13","author":[{"given":"Keya","family":"Trivedi","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03czfpz43","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Biology, Emory University","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3035-5331","authenticated-orcid":true,"given":"Christopher N.","family":"LaRock","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02gars961","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Microbiology and Immunology, Emory University School of Medicine","place":["Atlanta, USA"]},{"id":[{"id":"https:\/\/ror.org\/02gars961","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medicine, Division of Infectious Disease, Emory University School of Medicine","place":["Atlanta, USA"]},{"id":[{"id":"https:\/\/ror.org\/03czfpz43","id-type":"ROR","asserted-by":"publisher"}],"name":"Antimicrobial Resistance Center, Emory University","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/82_2012_280"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2023.102420"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00518"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.760255"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00659-1"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-025-01167-w"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/206033a0"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/166.1.31"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01392-07"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.87882"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177784"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0911811107"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.8.3369-3374.1993"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03470040097029"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004769"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2018.00010"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081298"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2015.02.010"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1004179"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2002.03146.x"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01116-07"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M704821200"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.11.078"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.11.7187-7189.2001"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2015.09.004"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2013.11.003"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-1825-3_136"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011321"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00405-24"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04717-x"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-017-0005-6"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00356-20"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1086\/323083"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aah3539"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI3065"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.11.6683-6686.2001"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-023-01583-9"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2010189"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2024.2327299"},{"key":"e_1_3_3_41_2","unstructured":"About the pathogen box. Med malar venture. 2025. Available from: https:\/\/www.mmv.org\/mmv-open\/pathogen-box\/about-pathogen-box. Retrieved 18 Apr 2025."},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00379-17"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104947"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa511"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.6.3523-3534.2000"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2009.08.046"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1101\/2024.10.10.615955"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1101\/2025.02.14.638345"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00258-23"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10556-8"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2011.07709.x"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004300050111"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1293095"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2022.105684"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118554"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adn7979"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/omi.12015"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-005-0001-y"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01640-17"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02006-16"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006673"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1128\/Spectrum.00739-21"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52176-8"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010809"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.5b00607"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.3c05323"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-04619-4"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00766-23"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01168-19"},{"key":"e_1_3_3_70_2","first-page":"385","article-title":"Suramin inhibits in vitro infection by duck hepatitis B virus, Rous sarcoma virus, and hepatitis delta virus","volume":"167","author":"Petcu DJ","year":"1988","unstructured":"Petcu DJ, Aldrich CE, Coates L, Taylor JM, Mason WS. 1988. Suramin inhibits in vitro infection by duck hepatitis B virus, Rous sarcoma virus, and hepatitis delta virus. Virology (Auckl) 167:385\u2013392.","journal-title":"Virology (Auckl)"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-016-0607-2"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2021.105944"},{"key":"e_1_3_3_73_2","first-page":"619","article-title":"Nebulized pentamidine for the prevention of Pneumocystis carinii pneumonia in AIDS patients: experience of 173 patients and a review of the literature","volume":"80","author":"Smith DE","year":"1991","unstructured":"Smith DE, Hills DA, Harman C, Hawkins DA, Gazzard BG. 1991. Nebulized pentamidine for the prevention of Pneumocystis carinii pneumonia in AIDS patients: experience of 173 patients and a review of the literature. Q J Med 80:619\u2013629.","journal-title":"Q J Med"},{"key":"e_1_3_3_74_2","first-page":"119","article-title":"Neutrophil-mediated host response to Porphyromonas gingivalis","volume":"4","author":"Kantarci A","year":"2002","unstructured":"Kantarci A, Van Dyke TE. 2002. Neutrophil-mediated host response to Porphyromonas gingivalis. J Int Acad Periodontol 4:119\u2013125.","journal-title":"J Int Acad Periodontol"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008x(91)90318-9"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900590"},{"key":"e_1_3_3_77_2","unstructured":"National Center for Biotechnology Information. 2025. PubChem compound summary for CID 4735 pentamidine. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Pentamidine. Retrieved 23 Apr 2025."}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.00758-25","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.00758-25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T13:05:26Z","timestamp":1754399126000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.00758-25"}},"subtitle":[],"editor":[{"given":"Justin R.","family":"Kaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":76,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,5]]}},"alternative-id":["10.1128\/spectrum.00758-25"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.00758-25","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.03.12.642885","asserted-by":"object"}]},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"2025-03-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00758-25"}}